| IDG | intermediate dose group |
|---|---|
| IDM | idiopathic disease of myocardium; immune defense mechanism; indirect method; infant of diabetic moth... |
| IFP | inflammatory fibroid polyp; insulin, compound F [hydrocortisone], prolactin; intermediate filament p... |
| ILL | intermediate lymphocytic lymphoma |
| IMCU | intermediate medical care unit |
| intermediate variable | A variable in a causal pathway that causes variation in the dependent variable and is itself caused to vary by the independent variable. (05 Mar 2000) |
|---|---|
| intermediate vastus muscle | <anatomy, muscle> Origin, upper three-fourths of anterior surface of shaft of femur; insertion, tibial tuberosity by way of common tendon of quadriceps femoris and patellar ligament; action, extends leg; nerve supply, femoral. Synonym: musculus vastus intermedius, crureus, femoral muscle, intermediate great muscle, intermediate vastus muscle. (05 Mar 2000) |
| intermediate vein of forearm | It begins at the base of the dorsum of the thumb, curves around the radial side, ascends the middle of the forearm, and just below the bend of the elbow divides into the intermediate basilic and intermediate cephalic veins; sometimes it divides lower down, one branch going to the basilic vein, the other to the intermediate vein of the elbow. Synonym: vena intermedia antebrachii, intermediate antebrachial vein, intermediate vein of forearm, median vein of forearm, vena mediana antebrachii. (05 Mar 2000) |
| transition state intermediate | In a chemical reaction, an unstable and high-energy configuration assumed by reactants on the way to making products. Enzymes are thought to bindand stabilise the transition state, thus lowering the energy of activation needed to drive the reaction to completion. (09 Oct 1997) |
| uveitis, intermediate | Inflammation of the pars plana, ciliary body, and adjacent structures. (12 Dec 1998) |
| lymphoma, intermediate-grade | One of the three major prognostic groupings for non-hodgkin lymphomas as proposed in the working formulation of the non-hodgkin's lymphoma pathologic classification project sponsored by the national cancer institute (1981). Lymphomas falling within this group have an intermediate survival potential. (12 Dec 1998) |